These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6557709)

  • 1. [Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].
    Baskova IP; Paskhina TS; Poliantseva LR; Iakubovskaia RI; Tiero A
    Vopr Med Khim; 1983; 29(5):96-9. PubMed ID: 6557709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
    Dotsenko VL; Iarovaia GA; Neshkova EA
    Vopr Med Khim; 1989; 35(2):128-33. PubMed ID: 2741408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A substrate inhibitor analysis of the urinary excretion of tissue and plasma kallikreins in patients with chronic glomerulonephritis].
    Platonova LV; Poliantseva LR; Filatova MP; Paskhina TS
    Urol Nefrol (Mosk); 1990; (4):38-43. PubMed ID: 2275058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromogenic peptide substrate assays in patients with multiple trauma.
    Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
    Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [State of the kinin system and level of serum proteinase inhibitors in latent nephritis and the nephrotic syndrome of different etiology].
    Paskhina TS; Poliantseva LR; Krinskaia AV; Belolipetskaia IuG; Nartikova VF
    Vopr Med Khim; 1977; 23(2):241-51. PubMed ID: 70111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
    Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
    Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and hydrolysis by arginyl-hydrolases of p-nitroanilide chromogenic substrates containing polyethylene glycol and D-gluconyl moieties.
    Juliano MA; Juliano L; Biondi L; Rocchi R
    Pept Res; 1991; 4(6):334-9. PubMed ID: 1821168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on components of the plasma kallikrein-kinin system in peritoneal fluid and plasma before and during experimental acute pancreatitis in pigs. A preliminary report.
    Ruud TE; Aasen AO; Kierulf P; Stadaas J; Aune S
    Acta Chir Scand Suppl; 1982; 509():89-93. PubMed ID: 6962625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton inventory studies of alpha-thrombin-catalyzed reactions of substrates with selected P and P' sites.
    Enyedy EJ; Kovach IM
    J Am Chem Soc; 2004 May; 126(19):6017-24. PubMed ID: 15137766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Components of kallikrein-kinin system in the urine of patients with glomerulonephritis].
    Paskhina TS; Poliantseva LR; Platonova LV; Levina GO
    Vopr Med Khim; 1990; 36(4):62-9. PubMed ID: 2173275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
    Ito R; Statland BE
    Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of a fibrinolytic enzyme from the larvae of Lonomia achelous (Cramer) using chromogenic peptide substrates.
    Arocha-Piñango CL; Pepper DS
    Thromb Haemost; 1981 Dec; 46(4):710-3. PubMed ID: 7330821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinin system components, free kinins and proteinase inhibitors in the edematous fluids of nephrotic syndrome patients].
    Paskhina TS; Poliantseva AR; Egorova TP; Krinskaia AV; Nartikova VF
    Vopr Med Khim; 1979; 25(5):588-99. PubMed ID: 91261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.